8 March 2019 - The topic of high prescription drug prices is now the dominant policy issue on Capitol Hill. The new Congress has held a half-dozen hearings on the topic. 

But one issue that is at the heart of high prices has attracted little attention: the role of biologic drugs in rising drug costs.

In 2017, biologic drugs represented 2% of all U.S. prescriptions, but 37% of net drug spending. Since 2014, biologic drugs account for nearly all of the growth in net drug spending: 93% of it, in fact.

Read Forbes article